
EGFR CA repeat polymorphism predict clinical outcome in EGFR mutation positive NSCLC patients treated with erlotinib
Keywords: Non-small cell lung cancer; CA repeat; Polymorphism; Erlotinib; Epidermal growth factor receptor; EGFR somatic mutations